Lonza, Corning Incorporated and Biotage are Dominating the Global Flow Chemistry Market in the year 2018

Global Flow Chemistry Market is expected to reach USD 2,489,571.94 thousand by 2026, growing with a health CAGR in the forecast period of 2019 to 2026. The years considered for study are as mentioned below.

Access Full Report at https://databridgemarketresearch.com/reports/global-flow-chemistry-market

The Global Flow Chemistry market is a highly concentrated market which includes key players and local players. The market has witnessed increased various strategic developments owing to favourable market scenario. The market has a prominent growth in upcoming years due to rising demand for technological advancements and increasing research and development activities in the healthcare industry.

The market has witness developments in terms of merger and acquisitions, partnerships or product launches to enhance the product portfolio to meet the rising demand of innovative technology. For instance in December 2018 Biotage acquired 100 percent shares of California based company, PhyNexus, Inc. for a price of USD 21.4 million. The acquisition strengthened the company as a chemical separator within the growing biomolecular segment. It will help the company to offer automated solutions for efficient purification of biomolecules.

Lonza dominated the global flow chemistry market. The other key players existing in the market includes Corning Incorporated and Biotage. The other key players existing in the market includes AM Technology, CEM Corporation, Syrris Ltd, Vapourtec Ltd., ThalesNano Inc., HEL GROUP, Uniqsis Ltd, CHEMTRIX, Zhengzhou Well-known Instrument & Equipment Co.Ltd., FutureChemistry, Parr Instrument Company, Cambridge Reactor Designs, PDC Machines Inc., Little Things Factory GmbH, Fraunhofer-Gesellschaft and YMC Engineering CO., LTD.

Lonza:

Lonza headquartered in Basel, Switzerland was founded in 1897. The company manufacturers integrated solutions for its pharma, healthcare and nutrition. The company operates through three business segments which include Pharma & Biotech and Speciality Ingredients.

The Pharma & Biotech segment mainly covers all Healthcare continuums. The segment includes clinical development and manufacturing, commercial manufacturing and consumables and research tools. The other segment includes solutions for nutritional ingredients, functional food, delivery forms and hygiene solutions. The other segment of the company includes coatings and composites solutions, agricultural products and services which include basic chemicals.

  • In July 2017, Lonza completed its acquisition of Capsugel USD 5.5 billion in cash. Capsugel company is a world leader in advanced oral dosage delivery technologies and will accelerate the growth of lonza’s healthcare continuum. The acquisition will help the company to develop its manufacturing facilities and product businesses

It has its global networks in the Asia-Pacific, Europe, North America and Rest Of World. It operates through its subsidiaries such as Lonza America Inc. (U.S.), Lonza Japan Ltd. (Japan), International School of Basel AG (Switzerland) etc.

Corning Incorporated:

Corning Incorporated Company headquartered in New York, U.S. was founded in 1936. The company is leading innovator in material sciences due to its deep manufacturing and engineering capabilities. The company operates through six business segments which include Optical Communications, Display Technologies, Speciality Materials, Environmental Technologies, Life Sciences and Others.        

The Life Science segment mainly deals mainly deals in innovative products for bioprocess and cell therapy. The segment works with researchers and drug manufacturers to increase efficiencies, reduce costs, and compress timelines. The other segments include substrates for high performance displays, including organic light emitting diode and liquid crystal displays that are used in television, notebook and flat panels of desktop monitors.

  • In October 2015, Corning announced a strategy and capital allocation framework which reflects the company’s financial and operational strengths. The framework will outline their leadership priorities and eloquent the opportunities which is their in the business.

It has its global networks through subsidiaries, R&D centres and manufacturing units in Americas, Asia-Pacific, Middle East and Africa and Europe. It operates through its subsidiaries such as Alliance Fiber Optic Products, Inc. (U.S.), Corning (Hainan) Optical Communications Co., Ltd. (China), Corning B.V. (Netherlands), China Corning Display Technologies Taiwan Co., Ltd. (Taiwan), Corning Holding GmbH (Germany), among others.

Biotage

Biotage is headquartered in Stockholm, Sweden founded in 1989. The company operates through three business segments which include Organic Chemistry, Analytical Chemistry, and Industrial Chemistry.

The Analytical segment is the focused segment which includes products that provide the analysis of various tests, for example, patient samples, forensic samples, and environmental and foodstuff samples. The products are used within many areas and for different types of analytical tests which will discover contaminants in soil, water and food. The other segment includes products which are used for synthesis and purification. Also the company deals products which include systems, consumables, and research services. The company also offer advanced research services which will help the customers to manufacture effective, custom consumables that help the customers to isolate substances from their products.

  • In December 2018, Biotage acquired 100 percent shares of California based company, PhyNexus, Inc. for a price of USD 21.5 million. The acquisition strengthened the company as a chemical separator within the growing biomolecular segment. It will help the company to offer automated solutions for efficient purification of biomolecules.

It has its global networks in Asia-Pacific, Europe, North America, South America, Asia-Pacific and Middle East & Africa. The company has various subsidiaries such as Pyrosequencing Inc. (U.S.), MIP Technologies AB (Sweden), Biotage GB Ltd (United Kingdom), Biotage Sweden Ab (Sweden), Biotage, LLC (U.S.), Separtis Holding AG (Germany), Horizon Technology, Inc. (U.S.)